Pfizer Says Plaintiffs Are Rehashing Nixed Zoloft Testimony
Pfizer Inc. argued Tuesday that plaintiffs in the federal multidistrict litigation over the antidepressant Zoloft are trying to repackage causation testimony by two experts that was excluded last year as case-specific...To view the full article, register now.
Already a subscriber? Click here to view full article